HYFM:NASDAQHydrofarm Holdings Group, Inc. Analysis
Data as of 2026-04-09 - not real-time
$0.98
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Hydrofarm Holdings Group (HYFM) is trading well below its 20‑day (≈$1.08), 50‑day (≈$1.25) and 200‑day (≈$2.55) simple moving averages, indicating a pronounced bearish price trend. The RSI sits at roughly 38, suggesting the stock is approaching oversold territory, while the MACD line has just nudged above its signal, delivering a faint bullish signal on an otherwise weak chart. Volume is on a decreasing trajectory, and the 30‑day volatility exceeds 100%, underscoring a highly erratic price environment. On the fundamentals side, the company reports a steep revenue decline of 32.7%, negative gross (≈11%) and operating margins (≈‑46%), and a massive net loss per share. Debt dwarfs cash, and both the P/E and P/B ratios are deeply negative, reflecting severe profitability challenges.
The latest material news confirms the release of the Q4 and full‑year 2025 results, which continue to show negative earnings and a deteriorating balance sheet. Combined with a market‑cap of under $5 M, thin trading volumes and a maximum drawdown near 79%, the stock presents a classic high‑risk, low‑valuation profile that may appeal only to speculative investors willing to tolerate extreme price swings.
The latest material news confirms the release of the Q4 and full‑year 2025 results, which continue to show negative earnings and a deteriorating balance sheet. Combined with a market‑cap of under $5 M, thin trading volumes and a maximum drawdown near 79%, the stock presents a classic high‑risk, low‑valuation profile that may appeal only to speculative investors willing to tolerate extreme price swings.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 3/10
Key Factors
- Bearish price trend below all major SMAs
- Decreasing volume and extreme short‑term volatility
- Continued negative earnings and widening losses
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential bottoming signal from MACD crossover
- Oversold RSI hinting at possible rebound
- Still substantial balance‑sheet weakness and debt burden
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Deep discount to sales (price‑to‑sales ~0.03) offering value upside
- Industry tailwinds for indoor controlled‑environment agriculture
- Persistent profitability issues and high drawdown risk
Key Metrics & Analysis
Financial Health
Revenue Growth-32.70%
Profit Margin-215.85%
P/E Ratio-1.6
ROE-361.28%
ROA-10.17%
P/B Ratio-0.1
Op. Cash Flow$-14059000
Free Cash Flow$5.6M
Industry P/E30.7
Technical Analysis
TrendBearish
RSI38.4
Support$0.97
Resistance$1.34
MA 20$1.08
MA 50$1.25
MA 200$2.55
MACDBullish
VolumeDecreasing
Fear & Greed Index83.54
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.35
Volatility108.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.